[fa icon="calendar'] Jan 30, 2018 9:00:00 AM / by Grant Wood posted in clinical genomics, artificial intellegence
HL7’s 3rd annual conference on genomics, February 20-21 in Washington, DC, combines professionals from multiple areas – technologists, academic research and commercial vendors, while mixing in policy and government, all from a global perspective. This year’s theme is Global Clinical Genomics, Artificial Intelligence and Innovation.
Health Level Seven® International (HL7) is an ANSI-accredited, not-for-profit standards developing organization with the mission of empowering global health interoperability. With affiliates in over 30 countries, HL7’s global membership envisions a world in which everyone can securely access and use the right data when and where they need it. Widely implemented by vendor and healthcare systems, and required by governing bodies around the world, HL7 standards deliver solutions for health information technology, including HL7® Fast Healthcare Interoperability Resources (FHIR®), Version 2 (V2) and Clinical Document Architecture (CDA®).
[fa icon="phone"] +1 (734) 677-7777
[fa icon="envelope"] HL7blog@HL7.org
